Antleron

19/04/2024

🔦 In today's episode of our Fellow Friday series, we shine a light on Britt Van Ballaer, ATMP Research & Development Architect: “Since 2021, the biolab at Antleron is my habitat where we delve deeper into how the performance of cell cultures is influenced by customized bioreactor conditions. By developing high-quality bioprocess concepts that are digitally tunable and economically viable, we contribute to a scalable, sustainable and personalized healthcare.”

Britt Van Ballaer: “I especially like the combination of hands-on lab work with innovative experimental design and the complementarity between biotech and engineering sciences.” 💉🧬🦠

Read complete Fellow Friday story 👉 https://www.antleron.com/post/britt-van-ballaer-develops-bioreactor-systems-in-support-of-scalable-bioprocesses-and-next-generatio

29/03/2024

It is Fellow Friday, and this time we are putting the entire team in the spotlight!

Our Antleron Fellows constitute a vibrant, multidisciplinary team of innovators that serves as the driving force of our organization. Our custom end-to-end scientific approach and proprietary technologies empower biomedical and biotechnology stakeholders to develop innovative, scalable and sustainable bioprocesses by generating unique data from R&D to GMP.

Beyond our intense daily collaboration and a relentless innovation drive, we foster a creative and friendly work environment. We regularly engage in brainstorming sessions to explore bioprocess innovation opportunities and indulge in enjoyable after-work activities.

To discover more about our Fellows, read this week’s brief Fellow Friday article:

Our Antleron Fellows constitute a vibrant, multidisciplinary team of innovators that serves as the driving force of our organization. Our Fellows, who originate from seven countries, are experts in biology, (bio)engineering, (bio)materials, (bio)medical, chemistry, computer science, and quality and....

12/09/2023

Earlier this month, on September 1, the new Flanders – Netherlands CrossRoads call for projects was launched. Symbolically, the inaugural event took place on the river Meuse, which meanders between both Dutch-speaking regions. The representative of the Flemish Minister of Economy and innovation, Jo Brouns, joined Elleen Theeuwes (chairwoman CrossRoads) and Bram de Kort (director Interreg Flanders-Netherlands) for the inauguration.

Re-experience the Crossroads event (incl. pictures and video): https://bit.ly/45U88bi

From September onwards, Flemish and Dutch SMEs will be able to submit proposals for innovative projects in sustainable entrepreneurship and energy, industry 4.0 and health.
More info and how to respond to CrossRoads project call: https://bit.ly/3PiFYQ3

Antleron CEO Jan Schrooten and Vivolta CEO ai Ramon Solberg were also present at the event to give a practical example of an interregional collaboration and the benefits of cross-border expertise exchanges for regenerative medicine.

27/07/2023

Seeking PhD Candidates! Join us in redefining the gene therapy landscape!

Antleron proudly partners with the Marie Skłodowska-Curie GET-IN Doctoral Network, addressing crucial knowledge gaps hindering gene therapy adoption. The network unites international academic and industry partners, fostering collaboration through diverse projects that nurture the next generation of gene therapy innovators.

Are you ready to embark on an ambitious innovation journey that will shape the future of gene therapy? The GET-IN network is actively seeking PhD candidates who possess the passion and determination to drive change in this field. By taking part in the activities of the Antleron team, you will focus on advancing upstream processing techniques for gene therapies. The two available projects are:

1. Viral vector production: tackling bottlenecks in efficiency and reproducibility.
2. Digital twin and multi-parametric optimisation of upstream unit operations for rAAV manufacturing.

Our innovative tools, including bioreactors, in silico process modeling, digital twins, and more, will empower you to make groundbreaking research contributions.

Learn more about GET-IN and its mission at www.get-in.org
Explore exciting PhD positions in collaboration with Antleron on our dedicated careers page at https://bit.ly/44J2rwa

02/06/2023

Dieter Hauwaerts brings strategic and operational ATMP excellence to the Antleron team. He is co-founder of Antleron and has acquired an impressive track record with leading pharma and biotech companies. Dieter shares his experience with the Antleron fellows to increase Antleron’s operational quality and efficiency, and strengthen its late-stage development capabilities. This will enable Antleron to more profoundly partner with leading international biotech stakeholders in jointly fast-tracking ATMP innovation to the patient. To clear his head, Dieter is active in various sports and outdoor activities. Read complete article:

Recently, Dieter Hauwaerts actively rejoined and strengthens the Antleron team. Dieter Hauwaerts: "My aim is to help define business strategies and put quality first in operations, targeting bioprocess development and GMP in a commercial context. We focus on embedding operational quality and efficie...

08/04/2023

Today, we finally introduce Maarten Sonnaert, Antleron’s first employee and currently our chief of operations. In this Fellow Friday, Maarten explains how he arrived on the pioneering and entrepreneurial journey with Antleron.

Maarten shares some insights into how his role has evolved within the company and the value of an open company culture in reaching innovation goals. Probably equally important is what Maarten is doing when you can’t reach him by phone or mail... Read story:

When not orchestrating the day-to-day operations and technology development at Antleron, Maarten Sonnaert can be found traversing wilderness areas all around the globe. Last year he led a hiking group in icy Greenland. Maarten, currently the COO of Antleron, was in fact the first employee to join th...